Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Thanakun, Supanee ^a   Watanabe, Hisashi ^b   Thaweboon, Sroisiri ^a   Izumi, Yuichi ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Leptin; Metabolic syndrome; Plasma; Saliva

Indexed keywords

EID: 84894420791     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-19     Document Type: Article

References (43)

1. Prevalence of metabolic syndrome in murcia region, a Southern European mediterranean area with low cardiovascular risk and high obesity. Gavrila D, Salmeron D, Egea-Caparros JM, Huerta JM, Perez-Martinez A, Navarro C, Tormo MJ, BMC Public Health 2011 11 562 10.1186/1471-2458-11-562 21752307
2. Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study. Gronner M, Bosi P, Carvalho A, Casale G, Contrera D, Pereira M, Diogo T, Braz J Med Biol Res 2011 44 713 719 21755260
3. Prevalence of metabolic syndrome among professional and office workers in Bangkok, Thailand. Lohsoonthorn V, Lertmaharit S, Williams M, J Med Assoc Thai 2007 90 1908 1915 17957937 (Pubitemid 350057154)
4. Prevalence of metabolic syndrome in the Canadian adult population. Riediger N, Clara I, CMAJ 2011 183 1127 E1134 10.1503/cmaj.110070 21911558
5. Metabolic syndrome: definitions and controversies. Kassi E, Pervanidou P, Kaltsas G, Chrousos G, BMC Med 2011 9 48 10.1186/1741-7015-9-48 21542944
6. Adiponectin and metabolic syndrome. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I, Arterioscler Thromb Vasc Biol 2004 24 29 33 10.1161/01.ATV. 0000099786.99623.EF 14551151 (Pubitemid 38082408)
7. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Brooks N, Moore K, Clark R, Perfetti M, Trent C, Combs T, Diabetes Obes Metab 2007 9 246 258 10.1111/j.1463-1326.2006.00596.x 17391150 (Pubitemid 46502042)
8. Leptin in human physiology and pathophysiology. Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim S-Y, Hamnvik O-PR, Am J Physiol Endocrinol 2011 301 567 E584 10.1152/ajpendo.00315.2011
9. Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome. Özçelik E, Uslu S, Kebapç N, Kara M, Dokumacoǧlu A, Musmul A, Diabetes Metab Syndrome: Clin Res Rev 2010 4 13 17 10.1016/j.dsx.2010.01.005
10. Adipokines, insulin resistance, and coronary artery calcification. Qasim A, Mehta N, Tadesse M, Wolfe M, Rhodes T, Girman C, Reilly M, J Am Coll Cardiol 2008 52 231 236 10.1016/j.jacc.2008.04.016 18617073 (Pubitemid 351915780)
11. Saliva as research material: biochemical, physicochemical and practical aspects. Schipper R, Silletti E, Vingerhoeds M, Arch Oral Biol 2007 52 1114 1135 10.1016/j.archoralbio.2007.06.009 17692813 (Pubitemid 350018725)
12. Circadian rhythmicity of salivary leptin in healthy subjects. Randeva H, Karteris E, Lewandowski K, Sailesh S, O'Hare P, Hillhouse E, Mol Genet Metab 2003 78 229 235 10.1016/S1096-7192(03)00004-0 12649069 (Pubitemid 36332025)
13. Measurement of salivary adiponectin levels. Toda M, Tsukinoki R, Morimoto K, Acta Diabetol 2007 44 20 22 10.1007/s00592-007-0236-8 17357881 (Pubitemid 46426958)
14. Salivary Adipokine Concentrations in Patients with Type 2 Diabetes. Jaedicke K, IADR AADR CADR 89th general session and exhibition 2011 March 16-19
15. An effective technique for the processing of saliva for the analysis of leptin and adiponectin. Thanakun S, Watanabe H, Thaweboon S, Izumi Y, Peptides 2013 47 60 65 23851006
16. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
17. Measurement of salivary resistin, visfatin and adiponectin levels. Mamali I, Roupas ND, Armeni AK, Theodoropoulou A, Markou KB, Georgopoulos NA, Peptides 2012 33 120 124 10.1016/j.peptides.2011.11.007 22108712
18. Measurement and validation of the nature of salivary adiponectin. Akuailou E-N, Vijayagopal P, Imrhan V, Prasad C, Acta Diabetol 2013 50 727 730 10.1007/s00592-012-0388-z 22415037
19. Comparison of biomarkers in blood and saliva in healthy adults. Williamson S, Munro C, Pickler R, Grap MJ, Elswick JR, Nurs Res Prac 2012 1 4 http://dx.doi.org/10.1155/2012/246178
20. Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence. Fernandez-Botran R, Miller JJ, Burns VE, Newton TL, Brain Behav Immun 2011 25 314 321 10.1016/j.bbi.2010.09.023 20888902
21. A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Aydin S, Halifeoglu I, Ozercan I, Erman F, Kilic N, Ilhan N, Ozkan Y, Akpolat N, Sert L, Caylak E, Peptides 2005 26 647 652 10.1016/j.peptides.2004.11.008 15752580 (Pubitemid 40326883)
22. Identification of leptin in human saliva. Gröschl M, Rauh M, Wagner R, Neuhuber W, Metzler M, Tamgüney G, Zenk J, Schoof E, Dörr HG, Blum WF, et al. J Clin Endocrinol Metab 2001 86 5234 5239 10.1210/jcem.86.11.7998 11701683 (Pubitemid 33070241)
23. Salivary leptin as a candidate diagnostic marker in salivary gland tumors. Schapher M, Wendler O, Gröschl M, Schäfer R, Iro H, Zenk J, Clin Chem 2009 55 914 922 10.1373/clinchem.2008.116939 19299541
24. Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. King GA, Deemer SE, Thompson DL, Acta Diabetol 2012 49 Suppl 1 41 S49 20454813
25. Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Kim J-Y, Ahn SV, Yoon J-H, Koh S-B, Yoon J, Yoo B-S, Lee S-H, Park J-K, Choe K-H, Guallar E, Diabetes Care 2013 36 1547 1553 10.2337/dc12-0223 23275369
26. Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Kim DH, Kim C, Ding EL, Townsend MK, Lipsitz LA, Hypertension 2013 62 27 32 10.1161/HYPERTENSIONAHA.113.01453 23716587
27. The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults. Chiu F-H, Chuang CH, Li W-C, Weng Y-M, Fann W-C, Lo H-Y, Sun C, Wang S-H, Cardiovasc Diabetol 2012 11 40 10.1186/1475-2840-11-40 22533665
28. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Wannamethee SG, Tchernova J, Whincup P, Lowe GDO, Kelly A, Rumley A, Wallace AM, Sattar N, Atherosclerosis 2007 191 418 426 16712853 (Pubitemid 46400705)
29. Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults? Wang Z, Zhuo Q, Fu P, Piao J, Tian Y, Xu J, Yang X, Diabetes/Metab Res 2010 26 109 114 10.1002/dmrr.1060
30. Metabolic risk susceptibility in Men is partially related to adiponectin/leptin ratio. Vega GL, Grundy SM, J Obes 2013 2013 9
31. Epidemiologic evidence on serum adiponectin level and lipid profile. Izadi V, Farabad E, Azadbakht L, Int J Of Preventive Med 2013 4 133 140
32. Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh T, Ohtsuka N, Lipids Health Dis 2011 10 79 10.1186/1476-511X-10-79 21586120
33. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Mojiminiyi O, Abdella N, Arouj M, Nakhi A, Inter J Obes 2007 31 213 220 10.1038/sj.ijo.0803355 (Pubitemid 46188199)
34. Adiponectin is associated with impaired fasting glucose in the Non-diabetic population. Kim SY, Lee SJ, Park HK, Yun JE, Lee M, Sung J, Jee SH, Epidemiol and Health 2011 33 2011007
35. The influence of age and body mass index on the metabolic syndrome and its components. Alexander CM, Landsman PB, Grundy SM, Diabetes Obes Metab 2008 10 246 250 10.1111/j.1463-1326.2006.00695.x 18269640 (Pubitemid 351247341)
36. Lower BMI cutoff for assessing the prevalence of metabolic syndrome in Thai population. Worachartcheewan A, Nantasenamat C, Isarankura-Na-Ayudhya C, Pidetcha P, Prachayasittikul V, Acta Diabetol 2010 47 91 96 10.1007/s00592-009- 0137-0 19649563
37. Adipokines and cardiometabolic function: How are they interlinked? Schutte AE, Huisman HW, Schutte R, van Rooyen JM, Malan L, Fourie CMT, Malan NT, Regul Pept 2010 164 133 138 10.1016/j.regpep.2010.06.008 20615436
38. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, et al. Diabetes 2002 51 2734 2741 10.2337/diabetes.51.9.2734 12196466 (Pubitemid 34970926)
39. Adipocytokine associations with insulin resistance in british South Asians. Webb DR, Khunti K, Chatterjee S, Jarvis J, Davies MJ, Exp Diabetes Res 2013 2013 7
40. Adipocytokine profiles as influenced by insulin resistance in obese subjects. Al-Daghri NM, Al-Attas OS, Sallam R, Diabetes & Metab Syndr: Clin Res & Rev 2009 3 79 83 10.1016/j.dsx.2009.02.004
41. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. Li S, Shin H, Ding E, RM vD, JAMA 2009 302 179 188 10.1001/jama.2009.976 19584347
42. Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M, Metab Syndr and Relat Disord 2009 7 447 452 10.1089/met.2008.0100
43. Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N, J Endocrinol Invest 2011 34 615 619 21164278